“…Regarding the latter, one may conclude that this system has the ability to produce PLT apheresis concentrates in a safe and, especially, economic manner. From our experience, citrate reactions very rarely occur at ACDA flow rates of up to 1·1 ml ACDA/min/l of donor blood volume [9,16,20,39]. Thus, it may be possible to increase individually the citrate flow rates for donors who are not sensitive to citrate, in order to reduce, even further, the procedure time without increasing the incidence of side‐effects such as citrate reactions.…”